Based on the key measurements obtained from Genprex's financial statements, Genprex is not in a good financial situation at this time. It has a very high odds of going through financial crisis in April. At this time, Genprex's Common Stock Total Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 15.4 M in 2025, whereas Property Plant And Equipment Net is likely to drop 8,586 in 2025. Key indicators impacting Genprex's financial strength include:
The financial analysis of Genprex is a critical element in measuring its lifeblood. Investors should not minimize Genprex's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income
(26.39 Million)
Genprex
Select Account or Indicator
Ptb Ratio
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Average Payables
Capex To Depreciation
Pb Ratio
Free Cash Flow Per Share
Roic
Net Income Per Share
Payables Turnover
Cash Per Share
Pocfratio
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Shareholders Equity Per Share
Capex Per Share
Graham Net Net
Enterprise Value Over E B I T D A
Price Earnings Ratio
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Effective Tax Rate
Company Equity Multiplier
Return On Capital Employed
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Cash Ratio
Cash Conversion Cycle
Free Cash Flow Operating Cash Flow Ratio
Price To Book Ratio
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Return On Assets
Price Fair Value
Return On Equity
Sale Purchase Of Stock
Change In Cash
Stock Based Compensation
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Total Cashflows From Investing Activities
Other Cashflows From Financing Activities
Depreciation
Capital Expenditures
Total Cash From Operating Activities
Change To Account Receivables
Change To Operating Activities
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Change To Netincome
Change To Liabilities
Investments
Other Cashflows From Investing Activities
Change To Inventory
Change Receivables
Other Non Cash Items
Cash And Cash Equivalents Changes
Cash Flows Other Operating
Issuance Of Capital Stock
Total Assets
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Net Tangible Assets
Property Plant And Equipment Net
Net Debt
Retained Earnings
Accounts Payable
Cash
Non Current Assets Total
Non Currrent Assets Other
Other Assets
Cash And Short Term Investments
Common Stock Total Equity
Common Stock Shares Outstanding
Liabilities And Stockholders Equity
Capital Surpluse
Other Current Assets
Other Stockholder Equity
Total Liab
Property Plant And Equipment Gross
Total Current Assets
Intangible Assets
Common Stock
Property Plant Equipment
Net Receivables
Short Long Term Debt Total
Retained Earnings Total Equity
Inventory
Net Invested Capital
Net Working Capital
Short Term Debt
Capital Stock
Depreciation And Amortization
Interest Expense
Selling General Administrative
Gross Profit
Other Operating Expenses
Operating Income
Net Income From Continuing Ops
Ebit
Research Development
Ebitda
Cost Of Revenue
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Net Income Applicable To Common Shares
Income Tax Expense
Net Interest Income
Interest Income
Reconciled Depreciation
Non Operating Income Net Other
Probability Of Bankruptcy
Understanding current and past Genprex Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Genprex's financial statements are interrelated, with each one affecting the others. For example, an increase in Genprex's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Genprex's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Genprex. Check Genprex's Beneish M Score to see the likelihood of Genprex's management manipulating its earnings.
Genprex Stock Summary
Genprex competes with Reviva Pharmaceuticals, Greenwich Lifesciences, Cognition Therapeutics, Eyenovia, and Transcode Therapeutics. Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas. Genprex operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 22 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
Cash flow analysis captures how much money flows into and out of Genprex. It measures of how well Genprex is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Genprex brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Genprex had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Genprex has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
Comparative valuation techniques use various fundamental indicators to help in determining Genprex's current stock value. Our valuation model uses many indicators to compare Genprex value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Genprex competition to find correlations between indicators driving Genprex's intrinsic value. More Info.
Genprex is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Genprex's Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Genprex's earnings, one of the primary drivers of an investment's value.
Genprex Systematic Risk
Genprex's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Genprex volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Genprex correlated with the market. If Beta is less than 0 Genprex generally moves in the opposite direction as compared to the market. If Genprex Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Genprex is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Genprex is generally in the same direction as the market. If Beta > 1 Genprex moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Genprex Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Genprex's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Genprex growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of Genprex help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Genprex. We use our internally-developed statistical techniques to arrive at the intrinsic value of Genprex based on widely used predictive technical indicators. In general, we focus on analyzing Genprex Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Genprex's daily price indicators and compare them against related drivers.
When running Genprex's price analysis, check to measure Genprex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genprex is operating at the current time. Most of Genprex's value examination focuses on studying past and present price action to predict the probability of Genprex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genprex's price. Additionally, you may evaluate how the addition of Genprex to your portfolios can decrease your overall portfolio volatility.